1 week Editas Medicine (EDIT) Reports Q4 Loss, Misses Revenue Estimates Zacks

Editas (EDIT) delivered earnings and revenue surprises of -41.03% and 19.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?